Page 6 - Pfizer

Pfizer fights to control secret of $36-billion Covid-19 jab recipe

Pfizer has begun to ramp up vaccine deliveries quickly outside the richest nations

Pfizer, Astra shots generate more antibodies than natural infection: Study

People who receive the Pfizer or AstraZeneca COVID-19 vaccine have antibody levels significantly higher than those infected with the SARS-CoV-2 virus, according to a study

Pfizer's oral Covid-19 drug may hit revenues of Divi's Laboratories

Supply of Molnupiravir to Merck was a key near-term trigger for the stock

S&P 500 hits record on strong jobs report, Pfizer Covid-19 pill cheer

US job growth regains momentum Pfizer jumps after positive Covid-19 antiviral pill data

Pfizer develops Covid pill that cuts hospitalisations and deaths by 89%

A pill that could be taken at home at the first sign of symptoms is a crucial tool for taming the Covid-19 crisis globally, so long as it's widely available

Wall St extends record rally on strong jobs report, Pfizer Covid pill cheer

October payrolls surge back as virus impact fades; travel stocks lead broader market gains

Top headlines: Pfizer's pill cuts risk of severe Covid; Delhi AQI worsens

Business Standard brings you the top headlines on Friday

Pfizer Ltd net profit rises 9% to Rs 143 crore in September quarter

The drug firm on Wednesday reported an 8.81% rise in net profit

'Turning point': Pfizer vaccine gets final nod for children over five

CDC Director Rochelle Walensky recommended the vaccine for children from 5 to 11 years old

Stocks to Watch: SBI, Airtel, SpiceJet, Trent, Mtar, Pfizer, HPCL, Bata

SBI and other banking shares, along with stocks of companies to report earnings today will be in focus

US gives final clearance to Pfizer's Covid-19 shots for kids 5 to 11

The decision marks the first opportunity for Americans under 12 to get the powerful protection of any COVID-19 vaccine.

US CDC advisors recommend Pfizer's Covid-19 vaccine for children aged 5-11

The vaccine is one-third the adult dose and the it would be given in two doses, three weeks apart. The lower dose was chosen to minimize side effects and still produce strong immunity, said Pfizer.

Third Pfizer vax dose more effective in reducing severe Covid: Lancet

A third vaccine dose of Pfizer-BioNTech is effective in reducing severe Covid related outcomes compared to individuals who have received two vaccine doses at least five months ago, finds a new study.

FDA paves way for Pfizer Covid-19 vaccinations in young kids

A few countries have begun using other COVID-19 vaccines in children under 12, including China, which just began vaccinations for 3-year-olds

US FDA advisers back Pfizer-BioNTech Covid-19 vaccine for children

The companies have said their vaccine showed 90.7% efficacy against the coronavirus in a clinical trial of children aged 5 to 11

US FDA says Pfizer Covid-19 vaccine looks effective for young kids

Federal health regulators said late Friday that kid-size doses of Pfizer's COVID-19 vaccine appear highly effective at preventing symptomatic infections in elementary school children

Pfizer says its Covid vaccine is 91% effective in kids of ages 5 to 11

The efficacy result is based on a trial of about 2,250 children, according to the briefing documents

US FDA clears Moderna, J&J booster shots; backs Covid-19 vaccine mixing

Pfizer and BioNTech said a booster shot of their Covid-19 vaccine restored full protection in a large study, results that are likely to bolster the argument for giving a third dose more widely

Top headlines: RIL shareholders approve Saudi appointment; setback for Zee

Business Standard brings you the top stories from today

Pfizer says its booster shot is 95.6% effective against symptomatic Covid

Regulators have wrestled with how widely to use boosters as the fast-spreading delta variant drives infection rates up